Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
6,824.66
(
0.62%
)
US TECH 100
24,403.20
(
0.66%
)
Dow Jones
48,185.80
(
0.58%
)
Brent Oil
94.45
(
-0.41%
)
Bitcoin
72,400.36
(
1.79%
)
News Focus
News Focus
Post# of 108195
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

jaxstraw

Send PM Follow Ignore
Followers 179
Posts 9202
Boards Moderated 1
Alias Born 05/01/2009

jaxstraw

Re: pitching51 post# 4690

Tuesday, 08/09/2016 6:25:10 PM

Tuesday, August 09, 2016 6:25:10 PM

Post# of 108195
PETX/Advaxis......

......conditional licensure in late-2016 or shortly thereafter.

Initiated AT-014 field study in dogs. During April 2016, Aratana initiated a field safety study for AT-014, an investigational canine osteosarcoma vaccine licensed from Advaxis, Inc. Aratana anticipates United States Department of Agriculture (USDA) conditional licensure in late-2016 or shortly thereafter.




Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today